Want to join the conversation?
$CRM is raising its FY17 guidance. For FY17, revenue is expected to be approx. $8.275-8.325Bil, an increase of 24-25% YoverY. GAAP diluted EPS is projected to be $0.27-0.29, while adjusted diluted EPS is projected to be $0.93-0.95. Operating cash flow growth is projected to be 20-21% YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?